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Introduction {#sec005}
============

Individuals with prediabetes and type 2 diabetes are recommended to engage in at least 150 min/week of moderate-to vigorous intensity physical activity (MVPA) \[[@pone.0181053.ref001]\]. Moderate intensity physical activity corresponds to repeated aerobic movement of large muscle groups such as walking, cycling, jogging and swimming (≥3 Metabolic Equivalents) \[[@pone.0181053.ref001], [@pone.0181053.ref002]\]. These recommendations are based on rigorous evidence \[[@pone.0181053.ref001], [@pone.0181053.ref003]\]. Yet, only a small proportion of the population with type 2 diabetes meets this recommendation \[[@pone.0181053.ref004], [@pone.0181053.ref005]\]. Reducing time in sedentary behavior (SB) and increasing time in light intensity physical activity (LPA) (standing, stepping and slow walking ≥1.6--2.9 Metabolic Equivalents) during the day is suggested as a first part of a stepped approach in increasing physical activity \[[@pone.0181053.ref002], [@pone.0181053.ref006], [@pone.0181053.ref007]\]. Emerging evidence also points at recommending interrupting SB alongside with being physically active. This may be especially beneficial to people with impaired glucose tolerance \[[@pone.0181053.ref008]--[@pone.0181053.ref010]\]. To underpin such recommendations more evidence is needed in terms of how often breaks in SB should be accomplished \[[@pone.0181053.ref011]\] and what intensity should be promoted to substitute the sedentary time \[[@pone.0181053.ref011], [@pone.0181053.ref012]\].

Physical activity is a complex behavior. During a day individuals are engaged in a pattern of behaviors at different intensities while awake: sedentary behavior (sitting/lying with low energy expenditure), standing and moving (stepping, walking, and exercising) at various bout lengths and with interruptions of different time lengths. When associating physical activity and SB with health parameters the whole-day pattern should be considered \[[@pone.0181053.ref006]\]. As time is finite, spending more time in one behavior inevitably reduces time in another behavior. For example, spending less time in SB may be replaced by time in LPA or in MVPA. When exploring the effects of reducing SB it is imperative to adjust for the behavior that it is replaced with to separate the effects \[[@pone.0181053.ref006], [@pone.0181053.ref011]\]. Isotemporal substitution methods have been suggested to model associations of reallocating time in one behavior for time in another with health \[[@pone.0181053.ref006], [@pone.0181053.ref013]\]. The model considers the fact that time is fixed (isotemporal) as well as the simultaneous relationships between activity intensities. A number of studies have used the isotemporal substitution paradigm in cross-sectional studies in both healthy populations e.g., \[[@pone.0181053.ref014], [@pone.0181053.ref015]\], in a population with impaired glucose control e.g. \[[@pone.0181053.ref016]\] and in populations with type 2 diabetes e.g., \[[@pone.0181053.ref017]--[@pone.0181053.ref019]\]. Beneficial associations with cardiometabolic risk factors have been demonstrated both of reallocating SB to MVPA e.g., \[[@pone.0181053.ref014]--[@pone.0181053.ref017], [@pone.0181053.ref019], [@pone.0181053.ref020]\] and to LPA e.g., \[[@pone.0181053.ref014], [@pone.0181053.ref016]--[@pone.0181053.ref018], [@pone.0181053.ref020]\], yet the evidence for LPA is still equivocal.

Recent studies also have reported health benefits of reallocating bouted sedentary time (≥ 30 min sedentary) to non-bouted sedentary time (sporadic sedentary time \< 30 min) in persons with diabetes but the findings are inconclusive \[[@pone.0181053.ref017], [@pone.0181053.ref018]\]. Most research on breaks in SB is using 30 minutes or less as a break-point for bouted SB. To our knowledge evidence is scarce for longer time intervals to break up a sedentary bout in the population with diabetes and prediabetes (impaired glucose control). This population is spending a large proportion of waking time sedentary and it is likely that this is in prolonged periods. More evidence is needed on the doses and patterns of SB, whether all duration of SB is similarly harmful \[[@pone.0181053.ref006], [@pone.0181053.ref011], [@pone.0181053.ref021]\] and on the effects of substituting sedentary time with LPA versus MVPA \[[@pone.0181053.ref021]\].

The aim of this study was to investigate the associations of reallocating sedentary time in bouts (\>60 min) to sedentary time in non-bouts, LPA or MVPA with cardiometabolic risk factors in a population diagnosed with prediabetes or type 2 diabetes.

Materials and methods {#sec006}
=====================

Participants {#sec007}
------------

This study reports baseline data obtained April 2013-November 2015 on a sample collected from the Sophia Step Study. A detailed description about the data collection can be found in the study protocol \[[@pone.0181053.ref022]\]. Patients at the health care centers of Sophiahemmet in Stockholm, Sweden diagnosed with prediabetes and type 2 diabetes meeting inclusion criteria were invited to participate. A total of 134 participants diagnosed with prediabetes or diabetes where recruited and measured by their diabetes specialist nurse. Participants gave full informed consent to participate in the study, and ethical approval was obtained from the Regional Ethical Review Board in Stockholm (Dnr.2012/1570-31/3).

*Inclusion criteria*: 40--80 years; ability to communicate in Swedish; having prediabetes (HbA~1c~ \> 39-\<47 mmol/mol and/or fasting glucose \>5.6 mmol/l) or diagnosed with type 2 diabetes for a duration of ≥1 year. *Exclusion criteria*: myocardial infarction in the past 6 months, serum creatinine \>140 mmol/l, diabetic foot ulcer or risk of ulcer (severe peripheral neuropathy), on insulin since the last 6 months, additional disease prohibiting physical activity, repeated hypoglycemia or severe hypoglycemia in the past 12 months, being classified in "very hard-intensity activity" category" according to the Stanford Brief Activity Survey \[[@pone.0181053.ref023]\] and having no access to internet.

Objectively measured physical activity and sedentary time {#sec008}
---------------------------------------------------------

Time spent in MVPA, LPA, total sedentary time and breaks in sedentary time were measured using the ActiGraph GT1M accelerometer (ActiGraph, Pensacola, FL). The participants were asked to wear the accelerometer placed on the lower back \[[@pone.0181053.ref024]\] during waking hours (except for swimming and bathing) for seven consecutive days. The accelerations were sampled at 10 Hz and data were summarized over one minute using ActiLife v.6.13.1 software. After comparison of wear time from participant's logs, non-wear time was set at \>90 minutes consecutive zero counts with allowance for two minutes interval of nonzero counts \[[@pone.0181053.ref025]\].

Data of more than 10 hours per day for more than 3 days were included in the analyses \[[@pone.0181053.ref026]\]. Valid wear time was divided into categories based on existing count-based thresholds SB \<100 counts per minute (cpm) \[[@pone.0181053.ref027]\]; LPA (100--1,951 cpm) and MVPA (≥1,952 cpm) \[[@pone.0181053.ref028]\]. Sedentary time was further split into "bouted" sedentary time based on uninterrupted periods of sedentary time of \>60 minutes and non-bouted, interrupted, sedentary time. Bouted sedentary time was defined as \>60min bouts of \<100 cpm with allowance for breaks ≥100 cpm \<1 min and non-bouted sedentary time as all other sedentary time (\< 100 cpm ≤59 minutes). If there was a break of ≥100 cpm \>1 minute that time was considered either as LPA or MVPA. Sedentary time in non-bouts is sedentary time with breaks more often than after 60 minutes. Bouted sedentary time is hereafter referred to as SB60 bouts and interrupted sedentary time as non-bouted SB. For explorative purposes the data was also split into \>40 and \> 20 minutes sedentary bouts and non-bouts.

Cardiometabolic biomarkers {#sec009}
--------------------------

Measurements included fasting blood samples of HbA~1c~ (mmol/mol and %), fasting plasma glucose (mmol/l), triglycerides (mmol/l), HDL cholesterol (mmol/l), LDL cholesterol (mmol/l) and resting systolic and diastolic blood pressure (mmHg). Analyzing methods for blood samples has been described in detail elsewhere \[[@pone.0181053.ref022]\]. Resting blood pressure was measured with Omron M6 Comfort. Anthropometric measurements included weight using a Tanita digital scale (Model TBF-300A, Arlington Heights, IL). Weight was measured with light clothing and no shoes to the nearest 0.1 kilogram. Height was measured at the first visit by use of a calibrated stadiometer to the nearest centimeter. Waist circumference was measured with SECA 201 tape, horizontal around the waist 2 cm above the umbilicus.

Sociodemographic and health behavior/status covariates {#sec010}
------------------------------------------------------

Sociodemographic variables included age, gender and education (university studies or not). Health status and use of medication was drawn from the medical records. Current medication (insulin, anti-diabetic tablets, statins and other cardiovascular disease (CVD) medications) was dichotomized into use of diabetes medication or not and use of CVD medication or not. Having other diseases (hyperlipidemia, hypertension, other CVDs (coronary heart disease and peripheral vascular disease), cancer, chronic obstructive pulmonary disease, inflammatory disease and other diseases) was dichotomized into having more than two other diseases or not. A questionnaire was e-mailed to the participants exploring dietary habits (type of cooking fat, amount fiber rich bread slices weekly) and daily fruits and vegetable intake) \[[@pone.0181053.ref029]\] and sleep quality (estimation of overall sleep quality, rating scale 1--5).

Statistical analysis {#sec011}
--------------------

All outcome variables were examined for normality and natural log transformations were performed for HbA1c, plasma glucose, triglycerides, systolic and diastolic blood pressure. For waist circumference, BMI, HDL cholesterol and LDL cholesterol, data approximated a normal distribution, the original values were retained and results are presented as unstandardized regression coefficients. For HbA1c, plasma glucose, triglycerides, systolic and diastolic blood pressure the unstandardized regression coefficients were back-transformed and are presented as relative rates (changes in the natural log of a variable are interpretable as percentage changes).

Covariate analyses were performed for each independent outcome. Age was included as a covariate in all models. All other covariates were retained only if p-value was \< 0.2 when all covariates were included in the model. Final retained covariates in each model are described in [S1 Table](#pone.0181053.s001){ref-type="supplementary-material"}.

Isotemporal substitution analysis was conducted to study the potential association of reallocating bouted sedentary time to different activity intensity and non-bouted sedentary time \[[@pone.0181053.ref013]\]. Regression models were used to explore associations of the exposure variables (bouted and non-bouted SB, LPA and MVPA) with cardiometabolic risk factors. All exposure variables were first converted to 30 min/day units to aid in interpretation of the regression coefficients. First, a single regression model examined the raw associations of each exposure and the health outcome with only covariates and wear time in the model. Second, a partition model examined the associations of each exposure variable after adjusting for all other exposure variables and covariates. Finally, isotemporal substitution models the associations of reallocating one exposure variable for another (e.g., SB60 bouts to MVPA), while adjusting for covariates as well as time in other activities. This was accomplished by including a total time variable (wear time based on Choi et al \[[@pone.0181053.ref025]\] in the model and dropping the exposure variable of interest. By replacing 30 minutes in one activity (e.g., SB60 bouts) with total time, the coefficient can be interpreted as the effect of replacing 30 minutes of SB60 bouts with the respective other activity in the regression (e.g., 30 minutes of MVPA). Additional analyses with sedentary time in sets of \>40- and \>20- minutes sedentary bouts and non-bouts, respectively, was also conducted for explorative purposes and are reported as supplementary material. Differences of interest were \>1.5 kg/m^2^ BMI, \>1.13 mmol/l HDL cholesterol \[[@pone.0181053.ref030]\] and \>4 mmol/l HbA1c \[[@pone.0181053.ref031]\].

IBM SPSS version 23.0 was used for all statistical analyses.

Results {#sec012}
=======

From 134 enrolled participants, 124 (93%) had valid accelerometer data and cardiometabolic biomarkers for inclusion in analyses. Mean age was 63.8 ± 7.5 years, 62 were women (50%), mean BMI was 29.7 ± 4.6. kg/m^2^ and a large proportion (60%) had university education. [Table 1](#pone.0181053.t001){ref-type="table"} displays participants characteristics per diagnose prediabetes or type 2 diabetes. Participants with type 2 diabetes had significantly higher (p\< 0.05) levels of HbA1c, plasma glucose, LDL cholesterol and triglycerides and a higher proportion had other diseases compared to participants with prediabetes. Participants with prediabetes spent significantly more total time in MVPA and a higher proportion had a university education. The mean duration of type 2 diabetes was 9.6 years. Most of the participants with type 2 diabetes (82.2%) and none of the participants with prediabetes used antidiabetic medication. A majority (79% diabetes, 64% prediabetes) used CVD medication.

10.1371/journal.pone.0181053.t001

###### Participant demographics by prediabetes and type 2 diabetes status.

![](pone.0181053.t001){#pone.0181053.t001g}

  ------------------------------------------------------------------------------------------------------------------------------
  n                                                                   Prediabetes\   Type 2 diabetes\   p         Total\
                                                                      33             91                           124
  ------------------------------------------------------------------- -------------- ------------------ --------- --------------
  **Age, years**                                                      64.8 (7.4)     63.5 (7.5)         0.375     63.8 (7.5)

  **Female**                                                          23             39                           62 (50)

  **University degree, yes**                                          20 (66.7)      51 (57.3)          0.370     71 (59.7)

  **Sleep quality, score**                                            2.3 (0.2)      2.4 (0.1)          0.592     2.26 (1.1)

  **Medications**                                                                                                 

   Insulin, yes                                                       0              16 (17.8)          \<0.09    16 (13.0)

   Diabetes tablets, yes                                              0              67 (74.4)          \<0.00    67 (54.5)

   Statins, yes                                                       12 (36.4)      54 (60.0)          0.020     66 (53.7)

   Other CVD medication, yes                                          16 (48.5)      56 (62.2)          0.173     72 (58.5)

  **Comorbidities**                                                                                               

   Hypertension, yes                                                  23 (71.9)      66 (73.3)          0.875     89 (73.0)

   Hyperlipidemia, yes                                                22 (68.8)      70 (77.8)          0.312     92 (75.4)

   Other CVD[^a^](#t001fn002){ref-type="table-fn"}, yes               3 (9.4)        22 (24.7)          0.067     25 (20.7

   Chronic obstructive pulmonary disease, yes                         3 (9.4)        15 (16.7)          0.322     18 (14.8)

   Inflammatory diseases, yes                                         2 (6.3)        3 (3.4)            0.487     5 (4.1)

   Cancer, yes                                                        2 (6.3)        7 (7.9)            0.768     9 (7.4)

   Other disease, yes                                                 9 (29.0)       21 (23.6)          0.551     30 (25.0)

  **Diet quality**                                                                                                

   Fruits and vegetables, daily servings                              2.9 (2.2)      2.8 (2.2)          0.862     2.8 (2.2)

   Cooking fat, butter[^b^](#t001fn003){ref-type="table-fn"}          1,6 (0.5)      1.7 (0.5)          0.421     1.7 (0.5)

   Fiber from bread, weekly slices                                    14.0 (10.3)    15.3 (11.3)        0.515     14.9 (11.0)

  **Cardio-metabolic biomarkers**                                                                                 

   Body Mass Index, kg/m^2^                                           29.0 (3.5)     30.0 (5.0)         0.314     29.7 (4.6)

   Waist circumference men, cm                                        105.0 (13.3)   108.5 (10.8)       0.367     108.0 (11.2)

   Waist circumference women, cm                                      96.8 (10.7)    100.5 (14.0)       0.281     99.2 (12.9)

   Systolic blood pressure, mmHg                                      126.7 (16.7)   132.0 (14.3)       0.088     130.6 (15.1)

   Diastolic blood pressure, mmHg                                     81.3 (9.3)     83.7 (9.2)         0.210     83.1 (9.3)

   HbA~1c~, mmol/mol (IFCC)                                           39.8 (4.1)     51.1 (11.0)        \<0.000   48.1 (10.8)

   HbA~1c~, % (DCCT)                                                  5.7 (0.4)      6.8 (1.1)          \<0.000   6.5 (1.0)

   Fasting plasma glucose, mmol/L                                     6.3 (0.7)      7.8 (1.7)          \<0.000   7.4 (1.6)

   C-Peptide nmol/L                                                   1.8 (1.4)      1.1 (0.5)          0.683     1.1 (0.8)

   HDL cholesterol, mmol/L                                            1.6 (0.4)      1.4 (0.4)          0.007     1.4 (0.4)

   LDL cholesterol, mmol/L                                            3.4 (0.7)      2.8 (1.0)          0.001     3.0 (1.0)

   Triglycerides, mmol/L                                              1.4 (0.5)      1.8 (0.9)          0.032     1.7 (0.9)

  **Physical activity and sedentary behavior**                                                                    

   Accelerometer wear time, min/day                                   836,8 (79.9)   835.7 (82.3)       0.833     834 (80.3)

   Moderate to vigorous intensity physical activity (MVPA), min/day   44.7 (28.4)    30.5 (21.0)        0.003     34.1 (24.1)

   Light physical activity (LPA), min/day                             242.4 (60.9)   222.7 (64.4)       0.134     224.4 (63.1)

   Total sedentary time, min/day                                      549.7 (93.7)   582.8 (78.5)       0.067     576.1 (82.0)

   Time in sedentary bouts \>60 min, min/day                          96.4 (79.5)    118.7 (71.8)       0.161     113.6 (73.5)

   Number of sedentary bouts \>60 min, n                              1.2 (0.9)      1.5 (0.9)          0.097     1.4 (0.9)
  ------------------------------------------------------------------------------------------------------------------------------

Table presents mean (standard deviation), sample n (%) or amount.

^a^ Coronary heart disease and peripheral vascular disease

^b^ Fat quality was dichotomized into Butter or oils and margarine

The raw associations of each exposure variable, adjusted for wear time, age and covariates, with cardiometabolic biomarkers (single model), are shown in [S2 Table](#pone.0181053.s002){ref-type="supplementary-material"}.

Results for biomarkers with significant associations (p\<0.05) in the partition model are displayed in [Table 2](#pone.0181053.t002){ref-type="table"}. When each exposure variable was adjusted also for time in other activities, beneficial associations for MVPA remained significant with BMI, waist circumference and HDL cholesterol. [S3 Table](#pone.0181053.s003){ref-type="supplementary-material"} shows the results of the partition model for total sedentary time, sedentary bouts of \>60/40/20 minutes and non-bouts.

10.1371/journal.pone.0181053.t002

###### Partition model for associations of each activity with cardio-metabolic biomarkers, adjusted for time in the other activities.

![](pone.0181053.t002){#pone.0181053.t002g}

  Regression coefficients (95% CI)   Relative rate (95% CI)                                                                                
  ---------------------------------- -------------------------- -------------------------- ----------------------- ----------------------- -----------------------
  SB60 bouts                         0.94 (-0.22, 2.10)         0.16 (-0.29, 0.61)         0.00 (-0.04, 0.04)      **1.02 (1.00, 1.04)**   1.00 (0.98, 1.02)
  Non-bouted SB                      0.32 (-0.67, 1.31)         -0.02 (-0.40, 0.36)        -0.02 (-0.06, 0.01)     -0.02 (-0.06, 0.01)     **0.98 (0.97, 1.00)**
  LPA                                -0.21 (-1.47, 1.05)        -0.12 (-0.60, 0.37)        0.01 (-0.03, 0.05)      1.01 (0.99, 1.03)       1.01 (0.98, 1.03)
  MVPA                               **-3.36 (-6.14, -0.59)**   **-1.31 (-2.38, -0.24)**   **0.12 (0.03, 0.21)**   1.02 (0.97, 1.07)       1.02 (0.96, 1.07)

Sedentary time was divided in 60 minutes or longer bouts (SB60 bouts) and other sedentary time (Non-bouted SB).

Bold indicates significant results (p\<0.05)

Physical activity intensity thresholds are \<100 counts/min for sedentary (SB), 100 to 1951 counts/min for light intensity physical activity (LPA) and ≥1952 for moderate and vigorous physical activity (MVPA).

[Table 3](#pone.0181053.t003){ref-type="table"} shows significant results (p\<0.05) from the isotemporal substitution analyses conducted for each exposure variable. Beneficial associations of similar effect size were observed for waist circumference, BMI and HDL cholesterol when 30 minutes of both SB60 bouts and non-bouted SB was reallocated to MVPA. Reallocating 30 minutes of SB60 bouts to LPA was also beneficially associated with waist circumference.

10.1371/journal.pone.0181053.t003

###### Isotemporal substitution model for associations of reallocated time in one activity to another activity with cardio-metabolic biomarkers.

![](pone.0181053.t003){#pone.0181053.t003g}

  Reallocation of:                                                    Regression coefficients (95% CI)                              
  ------------------------------------------------------------------- ---------------------------------- -------------------------- -----------------------
  SB60 bouts to non-bouted SB[^a^](#t003fn005){ref-type="table-fn"}   -0.62 (-1.78, 0.53)                -0.18 (-0.62, 0.27)        -0.03 (-0.07, 0.01)
  SB60 bouts to LPA                                                   **-1.15 (-2.27, -0.03)**           -0.27 (-0.70, 0.15)        0.01 (-0.03, 0.05)
  SB60 bouts to MVPA                                                  **-4.30 (-7.23, -1.38)**           **-1.46 (-2.60, -0.33)**   **0.11 (0.02, 0.21)**
  Non-bouted SB to LPA                                                -0.53 (-1.95, 0.89)                -0.10 (-0.65, 0.45)        0.04 (-0.01, 0.08)
  Non-bouted SB to MVPA                                               **-3.68 (-6.54, -0.83)**           **-1.29 (-2.39, -0.19)**   **0.14 (0.05, 0.23)**
  LPA to MVPA                                                         -3.15 (-6.38, 0.08)                -1.19 (-2.43, 0.05)        0.11 (-0.00, 0,21)

Bold indicates significant results (p\<0.05).

Physical activity intensity thresholds are \<100 counts/min for sedentary (SB), 100 to 1951 counts/min for light intensity physical activity (LPA) and ≥1952 for moderate and vigorous physical activity (MVPA).

Total time in each intensity was divided by a constant of 30, so that one unit of increase corresponds to 30 min exchange between one activity to another.

Total wear time was then entered together with covariates and all activities but one, simulating reallocation of 30 min in one activity by 30 min in another activity. By dropping each activity one by one the reallocating of time from different activities is modelled.

^a^ Sedentary time was divided in 60 minutes or longer bouts (SB60 bouts) and other sedentary time (Non-bouted SB60).

The same associations were observed when sedentary time was bouted in \>40- and \>20 minutes bouts, with the addition that reallocating 30 min from LPA to MVPA was beneficially associated with waist circumference, BMI and HDL cholesterol ([S4 Table](#pone.0181053.s004){ref-type="supplementary-material"}).

Not shown in [Table 3](#pone.0181053.t003){ref-type="table"}, due to very small beta coefficients, are the associations of SB60 bouts to LPA with diastolic blood pressure (RR = 0.99).

Discussion {#sec013}
==========

The findings of this study add to previous findings \[[@pone.0181053.ref017]\] that reallocating objectively measured time from SB to MVPA is beneficially associated with BMI, waist circumference and HDL cholesterol in persons with prediabetes and type 2 diabetes. The associations were of similar effect size when reallocating both bouted and non-bouted sedentary time to MVPA. Previous studies using the isotemporal method have reported significant beneficial associations of reallocating bouted SB (\> 30 min) also to LPA with waist circumference and BMI on similar populations \[[@pone.0181053.ref017], [@pone.0181053.ref018]\] and of reallocating 30 min of total SB to LPA with cardiometabolic benefits on healthy populations \[[@pone.0181053.ref014], [@pone.0181053.ref015]\]. In this study, the only association of reallocating SB to LPA was a slightly lower waist circumference when 30 minutes of bouted sedentary time (\>60 min) was reallocated to LPA. Also in contrast to what has been reported earlier \[[@pone.0181053.ref017], [@pone.0181053.ref018]\], although there were small associations, we did not find significant associations when reallocating SB60 bouts to non-bouted SB.

When splitting sedentary behavior in to \>40- and \>20 minutes sedentary bouts and non-bouts we found, consistent with previous findings, that reallocating time from LPA to MVPA was beneficially associated with BMI, waist circumference \[[@pone.0181053.ref017]\] and HDL cholesterol \[[@pone.0181053.ref014]\]. This implies that 30 minutes increase in MVPA has the most potential benefits on obesity parameters and HDL cholesterol. Several authors have demonstrated considerably stronger health associations by reallocating SB to MVPA than to LPA \[[@pone.0181053.ref011], [@pone.0181053.ref014]--[@pone.0181053.ref016], [@pone.0181053.ref019], [@pone.0181053.ref020]\].

The non-significant associations of reallocating SB60 bouts to non-bouted SB and SB to LPA in this study cannot be ruled out, but can be explained by the low amount of time spent in sedentary bouts (\>60 min) and the possible dose-response relationship of physical activity and health. More time is probably needed to be reallocated from SB to LPA and for bouted to non-bouts for potential associations. A recommendation to decrease total SB with 6o min/day has been proposed \[[@pone.0181053.ref006], [@pone.0181053.ref011]\] and if we would have chosen 60 min/day as units to be reallocated, the effect size would have been doubled. More research is needed on the health benefits of different patterns of activities and sedentary behavior, e.g. stratifying for number of sedentary bouts of different lengths and time in MVPA as well as different subgroups of the population with impaired glucose metabolism.

The inconsistency between this study and other studies on populations with type 2 diabetes can be explained by differences in terms of sample size, age range, gender distribution, disease duration and the fact that this study included persons with both prediabetes and type 2 diabetes. In this study the population had quite high education level, was more active than the general Swedish population with type 2 diabetes and the diabetes seemed to be well managed (the group with type 2 diabetes meet the target level for many clinical variables). Furthermore, using different devices for measuring physical activity and sedentary behavior and differences in the algorithms used to classify the data should be considered when making comparisons.

The three models revealed very small and mixed results on the metabolic parameters HbA1c and plasma glucose. None of the associations found in the single and partition model remained in the isotemporal model. Type 2 diabetes is a progressive condition and the included participants had various durations of both prediabetes and type 2 diabetes. The average HbA1c for the group with type 2 diabetes was below the Swedish target levels for populations with type 2 diabetes \[[@pone.0181053.ref032]\]. We did not control for the dose or type of medication and the absence of positive associations can be due to the fact that this was a well-medicated group of participants with type 2 diabetes and the inclusion of individuals with prediabetes. A broad spectrum of individuals across the diabetes continuum, including those at risk for diabetes as well as those with type 2 diabetes as well a wide age range was included in this study. Although this makes the interpretation of the results more difficult, it increases generalizability of our results and contributes to the knowledge of reducing risk and severity for type 2 diabetes.

In this study, reallocation of 30 minutes sedentary time to MVPA during a day was associated with clinically important differences of 1.46 kg/m^2^ in BMI and 0.14 mmol/l in HDLcholesterol. A reduction of 1.46 kg/m^2^ in BMI implies \~4 kg for individuals of 171 cm height and a weight difference of 5%, which has been confirmed to reduce the cardiovascular risk \[[@pone.0181053.ref030]\]. A difference of 0.14 mmol/l in HDL cholesterol can potentially lower the risk of coronary heart disease \[[@pone.0181053.ref033]\]. However, the results were not fully powered (0.71 and 0.79 for BMI and HDL cholesterol respectively) and the findings need to be confirmed by other data sets to eliminate the risk of false positive findings.

Strengths of this study include the objective measurements of physical activity and time spent sedentary and the range of outcome variables measured in a standardized way. Also, diet and sleep, factors influencing the outcomes were controlled for in the analyses.

Objective measures such as accelerometry are shown to have higher accuracy compared to self-reported levels of SB, LPA and MVPA. Yet, objective measures have some limitations. When exploring sedentary time, the data reduction procedure used to separate non-wear time from zero counts is a critical step and accelerometers are not sensitive enough to exclude misclassification of actual wear time as sedentary time and vice versa. In this study we chose \>90 minutes of consecutive zero counts (with allowance for two minutes interval of nonzero counts min) as non-wear time. This allowed for a daytime nap to be included as wear time and reduced the risk of excluding actual wear time. Moreover, by using accelerometers placed on the lower back we cannot separate sitting from standing. As a breakpoint for non-sedentary activity we have used \> 1 min breaks with cpm ≥ 100. Hence, this is regarded as LPA, corresponding to stepping or moving slowly for at least one minute and should not be mixed up with standing.

The pattern of sporadic, bouted and embedded MVPA and LPA was not considered in this study. We have used total time spent in LPA and MVPA, including all time \>1 min and did not divide these activity intensities into bouts, thus 30 min MVPA could be accumulated during the day and every minute had potential health enhancing effects. Time in MVPA is often embedded in LPA \[[@pone.0181053.ref034]\] and shorter sedentary bouts and interrupted sedentary time are possibly correlated with LPA. We did not adjust for the number of breaks of 1 minute or less during the bouted sedentary time, which can have health enhancing effects. The cut points used for MVPA and LPA should be considered with some caution as they are absolute and do not consider the fact that the potential health effects contributed by MVPA and LPA depends on current fitness level, age, genetic dispositions and other circumstances. In future studies, we suggest to control for fitness levels, as the most unfit individuals seem to benefit also at lower activity intensities \[[@pone.0181053.ref020]\].

The study has some limitations and interpretation of the associations must be made with caution. The participants had volunteered for a physical activity intervention and more than half were under both CVD and diabetes treatment. The data are cross-sectional and does not imply a causal relationship, yet the isotemporal models simulate changes, which can be considered as strength. The multiple regression analyses were run without adjusting the alpha level of significance and hence false positive errors cannot be ruled out. However, the number of statistical analyses run where reduced by including only biomarkers with significant results (p\<0.05) from the single to the partition analysis and from the partition to the isotemporal analysis.

Reducing time spent sedentary and frequently breaking up sitting could be parts of a stepped approach for better health, but emphasis should be to collect minutes of MVPA during the day. Advice must be individualized depending on the current individual physical activity pattern, fitness level, possibilities, readiness, daily routines and preferences.

Conclusion {#sec014}
==========

Reallocation of sedentary time in bouts as well as non-bouts to MVPA, but not to LPA, is beneficially associated with waist circumference, BMI and HDL cholesterol in individuals with prediabetes and type 2 diabetes. The results of this study confirm the importance of reallocation sedentary time to MVPA.

Supporting information {#sec015}
======================

###### Co-variates showing P\<0.2 in co-variate analysis were remained in the following analyses.

Age was adjusted for in all further analyses. Initially considered co-variates in all co-variates analyses were: gender; education (university studies or not), use of diabetes medication (insulin and oral tablets) or not; use of CVD medication or not; having more than to other diseases (including lung disease, hypertension, hyperlipidemia, other CVD (coronary heart disease and peripheral vascular disease), inflammatory disease, other co-morbidity and cancer) or not; sleep quality; fiber from bread (number slices per week), amount servings of fruits and vegetable per day and cooking fat quality.

(PDF)

###### 

Click here for additional data file.

###### Single model for cross-sectional associations of each 30 minutes per day of long bout sedentary time, non-bouted sedentary time, light intensity physical activity (LPA) and moderate to vigorous intensity (MVPA) with cardio-metabolic biomarkers.

Bold indicates significant results (p\<0.05)

Activity intensity tresholds are \<100 counts/min for sedentary (SB), 100 to 1951 counts/min for LPA and ≥1952 for MVPA.

^a^ Sedentary time was divided in 60 minutes or longer bouts (SB60) and non-bouted sedentary time (Non-bouted SB60).

^b^ Sedentary time was divided in 40 minutes or longer bouts (SB40) and non-bouted sedentary time (Non-bouted SB40).

^c^ Sedentary time was divided in 20 minutes or longer bouts (SB20) and non-bouted sedentary time (Non-bouted SB).\</SI_Caption\>

(PDF)

###### 

Click here for additional data file.

###### Partition model for cross-sectional associations of each 30 minutes per day of long bout sedentary time, non-bouted sedentary time, light intensity physical activity (LPA) and moderate to vigorous intensity (MVPA) with cardio-metabolic biomarkers, adjusted for time in the other activities.

Bold indicates significant results (p\<0.05)

Activity intensity tresholds are \<100 counts/min for sedentary (SB), 100 to 1951 counts/min for light intensity physical activity (LPA) and ≥1952 for MVPA.

^a^ Sedentary time was divided in 60 minutes or longer bouts (SB60) and non-bouted sedentary time (Non-bouted SB60).

^b^ Sedentary time was divided in 40 minutes or longer bouts (SB40) and non-bouted sedentary time (Non-bouted SB40).

^c^ Sedentary time was divided in 20 minutes or longer bouts (SB20) and non-bouted sedentary time (Non-bouted SB20).\</SI_Caption\>

(PDF)

###### 

Click here for additional data file.

###### Isotemporal substitution model for associations of reallocated time in one activity to another activity with cardio-metabolic biomarkers.

Bold indicates significant results (p\<0.05).

Activity intensity thresholds are \<100 counts/min for sedentary (SB), 100 to 1951 counts/min for light intensity physical activity and ≥1952 for MVPA.

Total time in each intensity was divided by a constant of 30, so that one unit of increase corresponds to 30 min exchange between one activity to another.

Total wear time was then entered together with covariates and all activities but one, simulating reallocation of 30 min in one activity by 30 min in another activity. By dropping each activity one by one the reallocating of time from different activities is modelled.

^a^ Sedentary time was divided in 60 minutes or longer bouts (SB60) and other sedentary time (Non-bouted SB60).

^b^ Sedentary time was divided in 40 minutes or longer bouts (SB40) and other sedentary time (Non-bouted SB40).

^c^ Sedentary time was divided in 20 minutes or longer bouts (SB20) and other sedentary time (Non-bouted SB20).\</SI_Caption\>

(PDF)

###### 

Click here for additional data file.
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